Crossref
journal-article
Elsevier BV
Neurobiology of Disease (78)
References
27
Referenced
29
10.1111/j.1365-2990.2004.00572.x
/ Neuropathol. Appl. Neurobiol. / Differential expression of alpha-synuclein isoforms in dementia with Lewy bodies by Beyer (2004)10.1016/j.molbrainres.2004.08.006
/ Brain Res. Mol. Brain Res. / Upregulation of amyloid precursor protein isoforms containing Kunitz protease inhibitor in dementia with Lewy bodies by Beyer (2004)10.1097/01.wnr.0000224773.66904.e7
/ NeuroReport / Low a-synuclein 126 mRNA levels in dementia with Lewy bodies and Alzheimer disease by Beyer (2006)10.1097/00001756-200109170-00017
/ NeuroReport / Co-association of parkin and alpha-synuclein by Choi (2001)10.1038/nm1001-1144
/ Nat. Med. / Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease by Chung (2001)10.1093/hmg/ddg159
/ Hum. Mol. Genet. / The p38 subunit of the aminoacyl–tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration by Corti (2003)10.1023/B:NERE.0000035807.25370.5e
/ Neurochem. Res. / Parkin transcript variants in rat and human brain by Dagata (2004)10.1038/8820
/ Nat. Genet. / Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions by Engelender (1999)10.1073/pnas.0509707103
/ Proc. Natl. Acad Sci. U. S. A. / Synphilin-1A: an aggregation-prone isoform of synphilin-1 that causes neuronal death and is present in aggregates from alpha-synucleinopathy patients by Eyal (2006)10.1097/00005072-199603000-00001
/ J. Neuropathol. Exp. Neurol. / Neuropathology of Parkinson’s disease by Forno (1996)10.1093/hmg/ddg269
/ Hum. Mol. Genet. / The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI by Huynh (2003)10.1016/S0092-8674(01)00407-X
/ Cell / An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin by Imai (2001)10.1007/BF00690978
/ Acta Neuropathol. (Berl.) / Lewy bodies in cerebral cortex, report of three cases by Kosaka (1978)10.1523/JNEUROSCI.4474-04.2005
/ J. Neurosci. / Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation by Lim (2005)10.1016/j.neurobiolaging.2005.07.023
/ Neurobiol. Aging / Parkin-mediated lysine 63-linked polyubiquitination: a link to protein inclusions formation in Parkinson’s and other conformational diseases? by Lim (2006)10.1093/hmg/ddg134
/ Hum. Mol. Genet. / Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson’s disease by Marx (2003)10.1016/S0304-3940(02)00253-7
/ Neurosci. Lett. / Analysis of synphilin-1 and synuclein interactions by yeast two-hybrid beta-galactosidase liquid assay by Neystat (2002)10.1016/S0169-328X(03)00337-1
/ Brain Res. Mol. Brain Res. / Quantifying mRNA in postmortem human brain: influence of gender, age at death, postmortem interval, brain pH, agonal state and inter-lobe mRNA variance by Preece (2003)10.1016/S0169-328X(03)00208-0
/ Brain Res. Mol. Brain Res. / An optimistic view for quantifying mRNA in post-mortem human brain by Preece (2003)10.1523/JNEUROSCI.23-08-03316.2003
/ J. Neurosci. / Parkin binds to alpha/beta tubulin and increases their ubiquitination and degradation by Ren (2003)10.1074/jbc.M201115200
/ J. Biol. Chem. / Synphilin-1 is developmentally localized to synaptic terminals, and its association with synaptic vesicles is modulated by alpha-synuclein by Ribeiro (2002)10.1038/77060
/ Nat. Genet. / Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase by Shimura (2000)10.1126/science.1060627
/ Science / Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson’s disease by Shimura (2001)10.1038/42166
/ Nature / Alpha-synuclein in Lewy bodies by Spillantini (1997)10.1002/1531-8249(200004)47:4<521::AID-ANA18>3.0.CO;2-B
/ Ann. Neurol. / Synphilin-1 is present in Lewy bodies in Parkinson’s disease by Wakabayashi (2000)10.1002/cne.1096
/ J. Comp. Neurol. / Parkin immunoreactivity in the brain of human and non-human primates: an immunohistochemical analysis in normal conditions and in Parkinsonian syndromes by Zarate-Lagunes (2001)10.1073/pnas.240347797
/ Proc. Natl. Acad Sci. U. S. A. / Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1 by Zhang (2000)
Dates
Type | When |
---|---|
Created | 18 years, 5 months ago (March 28, 2007, 3:19 a.m.) |
Deposited | 2 years, 6 months ago (Feb. 25, 2023, 1:32 a.m.) |
Indexed | 4 months, 3 weeks ago (April 13, 2025, 2:41 p.m.) |
Issued | 18 years, 3 months ago (June 1, 2007) |
Published | 18 years, 3 months ago (June 1, 2007) |
Published Print | 18 years, 3 months ago (June 1, 2007) |
@article{Humbert_2007, title={Parkin and synphilin-1 isoform expression changes in Lewy body diseases}, volume={26}, ISSN={0969-9961}, url={http://dx.doi.org/10.1016/j.nbd.2007.03.007}, DOI={10.1016/j.nbd.2007.03.007}, number={3}, journal={Neurobiology of Disease}, publisher={Elsevier BV}, author={Humbert, Jordi and Beyer, Katrin and Carrato, Cristina and Mate, José L. and Ferrer, Isidro and Ariza, Aurelio}, year={2007}, month=jun, pages={681–687} }